11,085.61
0.00
(0.00%)
As of January 7 at 9:10:45 AM CST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
1,820,700.00
1,813,800.00
1,490,800.00
2,089,400.00
1,484,800.00
Investing Cash Flow
-3,052,800.00
-360,100.00
1,370,800.00
-2,461,500.00
-940,600.00
Financing Cash Flow
70,000.00
-287,600.00
-2,572,300.00
43,000.00
-85,700.00
End Cash Position
2,460,800.00
2,770,100.00
1,600,700.00
1,306,000.00
1,638,500.00
Capital Expenditure
-1,234,700.00
-1,064,200.00
-532,400.00
-339,500.00
-341,500.00
Repurchase of Capital Stock
-66,300.00
-416,300.00
-2,607,400.00
--
-134,300.00
Free Cash Flow
586,000.00
749,600.00
958,400.00
1,749,900.00
1,143,300.00
12/31/2020 - 6/15/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
002223.SZ Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
35.20
-0.17%
CLPBY Coloplast A/S
11.02
+0.92%
COO The Cooper Companies, Inc.
90.35
+1.39%
WST West Pharmaceutical Services, Inc.
326.35
-0.79%
ALC Alcon Inc.
83.15
+0.50%
RMD ResMed Inc.
233.04
+1.84%
BLCO Bausch + Lomb Corporation
17.32
+0.46%
ANGO AngioDynamics, Inc.
12.19
+3.31%
POAI Predictive Oncology Inc.
1.2100
+0.83%
BDX Becton, Dickinson and Company
234.79
-0.43%